Esteve co-leads international consortium for the development of more efficacious therapies for neuropathic pain

Esteve co-leads international consortium for the development of more efficacious therapies for neuropathic pain

The NGN-PET consortium aims to explore neuron-glial interactions in subtypes of neuropathic pain which are induced by chemotherapy or trauma, and to develop human-predictive test systems that can be implemented in the drug discovery process. These cellular systems will use preclinical tissues and human iPSC-derived neuron-glia co-culturesin novel high-throughput screening platfor to identify novel more efficacious treatments for neuropathic pain…

Esteve co-leads international consortium for the development of more efficacious therapies for neuropathic pain

Esteve co-leads international consortium for the development of more efficacious therapies for neuropathic pain

NGN-PET is a project launched in the framework of the Innovative Medicine Initiative (IMI), the largest public-private partnership (PPP) for health research worldwide co-funded by the EU and the European pharmaceutical industry. ESTEVE, along with five other partners, is part of this project for the development of novel, more efficacious treatments for chronic pain of neuropathic origin Neuropathic pain affects…

Esteve co-leads international consortium for the development of more efficacious therapies for neuropathic pain

Esteve co-leads international consortium for the development of more efficacious therapies for neuropathic pain

Esteve at the Barcelona Science Park co-leads the NGN-PET consortium, that unites the expertise and knowledge of industry partners from the European Federation of Pharmaceutical Industries and Associations (EFPIA), small and medium-sized enterprises (SMEs) and academia for the development of novel, more efficacious treatments for chronic pain of neuropathic origin. NGN-PET is a project launched in the framework of the Innovative Medicine Initiative (IMI), the largest…

NGN-PET Project Launch

NGN-PET Project Launch

Launch of the project: Modelling neuron-glia networks into a drug discovery platform for pain efficacious treatments (NGN-PET) The new research project NGN-PET was launched in the framework of the Innovative Medicine Initiative (IMI), the largest public-private partnership (PPP) for health research worldwide co-funded by the EU and the European pharmaceutical industry. The NGN-PET consortium unites the expertise and knowledge of…